Globus Medical IncGMED
Price$74.41Intrinsic value$153.43106% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $153.43median of 6 methods · middle span $81-$190based on filings through 30 Jun 2026
Market Price $74.41Price as of 1 Oct 2026
Margin of Safety +106.2%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 14.7% (near-term consensus, capped) · years 2–5: 13.5%/yr (balance of the path).13.7% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 613.6%Yr 713.6%Yr 813.6%Yr 913.7%Yr 1013.7%
13.5% → 13.7%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1112.7%Yr 1211.6%Yr 1310.5%Yr 149.4%Yr 158.4%Yr 167.3%Yr 176.2%Yr 185.1%Yr 194.1%Yr 203.0%
13.7% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)17.1%
Discount rate (cost of equity) 9.3%
Volatility vs market (adjusted beta)0.97

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetGlobus Medical IncGMEDHealth Care
Valuation
P/E19.0×
P/S3.2×
P/B2.1×
EV / Revenue3.0×
EV / EBITDA10.5×
Profitability
Gross margin67.4%
Operating margin16.3%
Net margin17.0%
FCF margin24.0%
Returns
ROE11.2%
ROA9.8%
ROIC12.2%
Growth
Revenue growth (YoY)24.8%
5-yr fwd EPS growth13.7%
Financial strength
Debt / Equity0.02×
Current ratio4.62×
Altman Z-Score10.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.